310 related articles for article (PubMed ID: 34560539)
1. The role of microbiota in respiratory health and diseases, particularly in tuberculosis.
Shah T; Shah Z; Baloch Z; Cui X
Biomed Pharmacother; 2021 Nov; 143():112108. PubMed ID: 34560539
[TBL] [Abstract][Full Text] [Related]
2. The host microbiome and impact of tuberculosis chemotherapy.
O'Toole RF; Gautam SS
Tuberculosis (Edinb); 2018 Dec; 113():26-29. PubMed ID: 30514510
[TBL] [Abstract][Full Text] [Related]
3. The Host Microbiota Contributes to Early Protection Against Lung Colonization by
Dumas A; Corral D; Colom A; Levillain F; Peixoto A; Hudrisier D; Poquet Y; Neyrolles O
Front Immunol; 2018; 9():2656. PubMed ID: 30487801
[TBL] [Abstract][Full Text] [Related]
4. The gut and lung microbiota in pulmonary tuberculosis: susceptibility, function, and new insights into treatment.
Zhuo Q; Zhang X; Zhang K; Chen C; Huang Z; Xu Y
Expert Rev Anti Infect Ther; 2023; 21(12):1355-1364. PubMed ID: 37970631
[TBL] [Abstract][Full Text] [Related]
5. The human microbiota in pulmonary tuberculosis: Not so innocent bystanders.
Tarashi S; Ahmadi Badi S; Moshiri A; Nasehi M; Fateh A; Vaziri F; Siadat SD
Tuberculosis (Edinb); 2018 Dec; 113():215-221. PubMed ID: 30514505
[TBL] [Abstract][Full Text] [Related]
6. Gut Mycobiota Dysbiosis in Pulmonary Tuberculosis Patients Undergoing Anti-Tuberculosis Treatment.
Cao D; Liu W; Lyu N; Li B; Song W; Yang Y; Zhu J; Zhang Z; Zhu B
Microbiol Spectr; 2021 Dec; 9(3):e0061521. PubMed ID: 34908436
[TBL] [Abstract][Full Text] [Related]
7. Microbiome-immune interactions in tuberculosis.
Mori G; Morrison M; Blumenthal A
PLoS Pathog; 2021 Apr; 17(4):e1009377. PubMed ID: 33857251
[TBL] [Abstract][Full Text] [Related]
8. The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?
Eribo OA; du Plessis N; Ozturk M; Guler R; Walzl G; Chegou NN
Cell Mol Life Sci; 2020 Apr; 77(8):1497-1509. PubMed ID: 31729564
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs.
Hu Y; Yang Q; Liu B; Dong J; Sun L; Zhu Y; Su H; Yang J; Yang F; Chen X; Jin Q
J Infect; 2019 Apr; 78(4):317-322. PubMed ID: 30107196
[TBL] [Abstract][Full Text] [Related]
10. The microbiome at the pulmonary alveolar niche and its role in Mycobacterium tuberculosis infection.
Adami AJ; Cervantes JL
Tuberculosis (Edinb); 2015 Dec; 95(6):651-658. PubMed ID: 26455529
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium tuberculosis, antimicrobials, immunity, and lung-gut microbiota crosstalk: current updates and emerging advances.
Osei Sekyere J; Maningi NE; Fourie PB
Ann N Y Acad Sci; 2020 May; 1467(1):21-47. PubMed ID: 31989644
[TBL] [Abstract][Full Text] [Related]
12. The Manipulation of the Lipid Mediator Metabolism as Adjunct Host-Directed Therapy in Tuberculosis.
Nienaber A; Hayford FEA; Variava E; Martinson N; Malan L
Front Immunol; 2021; 12():623941. PubMed ID: 33777003
[TBL] [Abstract][Full Text] [Related]
13. The gut microbiome: A line of defense against tuberculosis development.
Yu Z; Shen X; Wang A; Hu C; Chen J
Front Cell Infect Microbiol; 2023; 13():1149679. PubMed ID: 37143744
[TBL] [Abstract][Full Text] [Related]
14. The lung microbiome, vitamin D, and the tuberculous granuloma: A balance triangle.
Balcells ME; Yokobori N; Hong BY; Corbett J; Cervantes J
Microb Pathog; 2019 Jun; 131():158-163. PubMed ID: 30953746
[TBL] [Abstract][Full Text] [Related]
15. Microbiome Changes during Tuberculosis and Antituberculous Therapy.
Hong BY; Maulén NP; Adami AJ; Granados H; Balcells ME; Cervantes J
Clin Microbiol Rev; 2016 Oct; 29(4):915-26. PubMed ID: 27608937
[TBL] [Abstract][Full Text] [Related]
16. Intestinal microbiota disruption limits the isoniazid mediated clearance of Mycobacterium tuberculosis in mice.
Negi S; Pahari S; Bashir H; Agrewala JN
Eur J Immunol; 2020 Dec; 50(12):1976-1987. PubMed ID: 32673409
[TBL] [Abstract][Full Text] [Related]
17. The microbiome and tuberculosis: state of the art, potential applications, and defining the clinical research agenda.
Naidoo CC; Nyawo GR; Wu BG; Walzl G; Warren RM; Segal LN; Theron G
Lancet Respir Med; 2019 Oct; 7(10):892-906. PubMed ID: 30910543
[TBL] [Abstract][Full Text] [Related]
18. Correlation between Disease Severity and the Intestinal Microbiome in Mycobacterium tuberculosis-Infected Rhesus Macaques.
Namasivayam S; Kauffman KD; McCulloch JA; Yuan W; Thovarai V; Mittereder LR; Trinchieri G; Barber DL; Sher A
mBio; 2019 Jun; 10(3):. PubMed ID: 31164469
[TBL] [Abstract][Full Text] [Related]
19. Neutrophils in Tuberculosis-Associated Inflammation and Lung Pathology.
Muefong CN; Sutherland JS
Front Immunol; 2020; 11():962. PubMed ID: 32536917
[TBL] [Abstract][Full Text] [Related]
20. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
Raftery AL; Tsantikos E; Harris NL; Hibbs ML
Front Immunol; 2020; 11():2144. PubMed ID: 33042125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
